Identification of interaction between PAI-2 and IRF-3

Acta Biochimica et Biophysica Sinica

Volumn 35, Issue 7, 2003, Pages 661-665

  Zhang, Yu Qing ^a   Li, Ping ^a   Hou, Min ^a   Wang, Xia ^a   Fan, Jing ^a   Tan, Li ^a   Zhu, Yun Song ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Co immunoprecipitation; Interferon regulatory factor 3 (IRF 3); Plasminogen activator inhibitor type 2 (PAI 2); Yeast two hybrid system

Indexed keywords

COMPLEMENTARY DNA; INTERFERON REGULATORY FACTOR 3; PLASMINOGEN ACTIVATOR INHIBITOR 2; TUMOR NECROSIS FACTOR ALPHA;

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DNA LIBRARY; FEMALE; HELA CELL; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOLECULAR CLONING; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TWO HYBRID SYSTEM;

APOPTOSIS; DNA-BINDING PROTEINS; GENE LIBRARY; HELA CELLS; HUMANS; INTERFERON REGULATORY FACTOR-3; PLASMINOGEN ACTIVATOR INHIBITOR 2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTOR-ALPHA; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 0042071201     PISSN: 05829879     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Tian Y, Shen JQ, Li P, Zhu YS. The protection function of the PAI-2 from TNF-α is denpendent upon its protein binding domain. Acta Biochim Biophys Sin, 2000, 32: 175-178
2. Dickinson JL, Norris BJ, Jensen PH, Antalis TM. The CD interhelical domain of the serpin plasminogen activator inhibitor-type2 is required for prtection from TNF-α induced apoptosis. Cell Death Differ, 1998, 5: 163-171
3. Hoffman CS, Winston F. A ten-minute DNA preparation from yeast efficiently releases autonomous plasmids for transformation of Escherichia coli Gene, 1987, 57: 267-272
4. Kumar KP, McBride KM, Weaver BK, Dingwall C, Reich NC. Regulated nuclear-cytoplasmic localization of interferon regulatory factor 3, a subunit of double-stranded RNA-activated factor 1. Mol Cell Biol, 2000, 20: 4159-4168
5. Heylbroeck C, Balachandran S, Servant MJ, DeLuca C, Barber GN, Lin R, Hiscott J. The IRF-3 transcription factor mediates Sendai virus-induced apoptosis. J Virol, 2000, 74: 3781-3792
6. Weaver BK, Ando O, Kumar KP, Reich NC. Apoptosis is promoted by the dsRNA-activated factor (DRAF1) during viral infection independent of the action of interferon or p53. FASEB J, 2001, 15: 501-515
7. Schulze-Osthoff K, Ferrari D, Los M, Wesselborg S, Peter ME. Apoptosis signaling by death receptors. Eur J Biochem, 1998, 254: 439-459
8. Suk K, Kim YH, Chang I, Kim JY, Choi YH, Lee KY, Lee MS. IFN alpha sensitizes ME-180 human cervical cancer cells to TNFalpha-induced apoptosis by inhibiting cytoprotective NF-kappaB activation. FEBS Lett, 2001, 495: 66-70
9. Medcalf RL, Kruithof EK, Schleuning WD. Plasminogen activator inhibitor 1 and 2 are tumor necrosis factor / cachectin-responsive genes. J Exp Med, 1988, 168: 751-759
10. Lin R, Mamane Y, Hiscott J. Structural and functional analysis of interferon regulatory factor 3: Localization of the transactivation and autoinhibitory domains. Mol Cell Biol, 1999, 19: 2465-2474
11. Antalis TM, la Linn M, Donnan K, Mateo L, Gardner J, Dickinson JL, Buttigieg K et al. The serine proteinase inhibitor (serpin) plasminogen activation inhibitor type 2 protects against viral cytopathic effects by constitutive interferon α/β priming. J Exp Med, 1998, 187: 1799-1811
12. Shafren DR, Gardner J, Mann VH, Antalis TM, Suhrbier A. Picornavirus receptor down-regulation by plasminogen activator inhibitor type 2. J Virol, 1999, 73: 7193-7198